Skip to main content
. 2020 Jul 9;59(37):16225–16232. doi: 10.1002/anie.202002147

Figure 4.

Figure 4

Glycoform abundances in bevacizumab fermentation samples (day 5, day 10, day 14), antibody purified via protein A affinity chromatography after 15 days of fermentation (capture eluate), and the reference product (Avastin®) before (observed) and after (actual) correction for the hexosylation bias. Error bars represent (propagated) 95 % confidence intervals from three technical replicates. See Table S1 for the abbreviations of glycan structures.